
Key takeaways:
- Vaccine maker AIM has filed for an IPO in Hong Kong, following unsuccessful previous bids in Hong Kong and on Shenzhen’s ChiNext board
- The company has three Covid vaccines under development, including an mRNA vaccine expected to hit the market in the fourth quarter